Chronic metabolic acidosis (CMA) is a common complication of the more advanced stages of chronic kidney diseases (CKD), and is associated with morbidity and mortality of CKD patients and possibly with the progression of renal disease. Nevertheless, there is limited evidence or information on the prevalence, the potential causal factors, the clinical impact and the effects of correction of CMA in kidney transplant recipients. In this review, we briefly look at the more relevant, though scanty, studies which have, over time, addressed the above-mentioned points, with the hope that in the future the interest of transplant nephrologists and surgeons will grow towards this unreasonably neglected issue.
|Titolo:||Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance|
|Parole Chiave:||allograft dysfunction; metabolic acidosis; renal transplantation|
|Settore Scientifico Disciplinare:||Settore MED/14 - Nefrologia|
|Data di pubblicazione:||2016|
|Data ahead of print / Data di stampa:||2015|
|Digital Object Identifier (DOI):||10.1093/ndt/gfv098|
|Appare nelle tipologie:||01 - Articolo su periodico|